|
1
|
Herr HW and Morales A: History of bacillus
Calmette-Guerin and bladder cancer: an immunotherapy success story.
J Urol. 179:53–56. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ratliff TL, Palmer JO, McGarr JA and Brown
EJ: Intravesical Bacillus Calmette-Guerin therapy for murine
bladder tumors: Initiation of the response by fibronectin-mediated
attachment of Bacillus Calmette-Guérin. Cancer Res. 47:1762–1766.
1987.PubMed/NCBI
|
|
3
|
Kuroda K, Brown EJ, Telle WB, Russell DG
and Ratliff TL: Characterization of the internalization of bacillus
Calmette-Guerin by human bladder tumor cells. J Clin Invest.
91:69–76. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen F, Zhang G, Iwamoto Y and See WA:
Bacillus Calmette-Guerin initiates intracellular signaling in a
transitional carcinoma cell line by cross-linking alpha 5 beta 1
integrin. J Urol. 170:605–610. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Redelman-Sidi G, Iyer G, Solit DB and
Glickman MS: Oncogenic activation of Pak1-dependent pathway of
macropinocytosis determines BCG entry into bladder cancer cells.
Cancer Res. 73:1156–1167. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pook SH, Esuvaranathan K and Mahendran R:
N-acetylcysteine augments the cellular redox changes and cytotoxic
activity of internalized mycobacterium bovis in human bladder
cancer cells. J Urol. 168:780–785. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shah G, Zhang G, Chen F, Cao Y,
Kalyanaraman B and See WA: iNOS expression and NO production
contribute to the direct effects of BCG on urothelial carcinoma
cell biology. Urol Oncol. 32:45.e1–9. 2014. View Article : Google Scholar
|
|
8
|
Zhang G, Chen F, Cao Y, Amos JV, Shah G
and See WA: HMGB1 release by urothelial carcinoma cells in response
to Bacillus Calmette-Guérin functions as a paracrine factor to
potentiate the direct cellular effects of Bacillus Calmette-Guérin.
J Urol. 190:1076–1082. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Méndez-Samperio P, Pérez A and Torres L:
Role of reactive oxygen species (ROS) in Mycobacterium bovis
bacillus Calmette Guérin-mediated up-regulation of the human
cathelicidin LL-37 in A549 cells. Microb Pathog. 47:252–257. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rahmat JN, Esuvaranathan K and Mahendran
R: Bacillus Calmette-Guérin induces cellular reactive oxygen
species and lipid peroxidation in cancer cells. Urology.
79:1411.e15–e20. 2012. View Article : Google Scholar
|
|
11
|
De Boer EC, Rooijakkers SJ, Schamhart DH
and Kurth KH: Cytokine gene expression in a mouse model: The first
instillations with viable bacillus Calmette-Guerin determine the
succeeding Th1 response. J Urol. 170:2004–2008. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rentsch CA, Birkhäuser FD, Biot C, Gsponer
JR, Bisiaux A, Wetterauer C, Lagranderie M, Marchal G, Orgeur M,
Bouchier C, et al: Bacillus Calmette-Guérin strain differences have
an impact on clinical outcome in bladder cancer immunotherapy. Eur
Urol. 66:677–688. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Secanella-Fandos S, Luquin M and Julián E:
Connaught and Russian strains showed the highest direct antitumor
effects of different Bacillus Calmette-Guérin substrains. J Urol.
189:711–718. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pook SH, Rahmat JN, Esuvaranathan K and
Mahendran R: Internalization of mycobacterium bovis, bacillus
calmette guerin, by bladder cancer cells is cytotoxic. Oncol Rep.
18:1315–1320. 2007.PubMed/NCBI
|
|
15
|
Pastorian K, Hawel L III and Byus CV:
Optimization of cDNA representational difference analysis for the
identification of differentially expressed mRNAs. Anal Biochem.
283:89–98. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Seow SW, Rahmat JN, Bay BH, Lee YK and
Mahendran R: Expression of chemokine/cytokine genes and immune cell
recruitment following the instillation of mycobacterium bovis,
bacillus calmette-guerin or lactobacillus rhamnosus strain GG in
the healthy murine bladder. Immunology. 124:419–427. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hwang NR, Yim SH, Kim YM, Jeong J, Song
EJ, Lee Y, Lee JH, Choi S and Lee KJ: Oxidative modifications of
glyceraldehyde-3-phosphate dehydrogenase play a key role in its
multiple cellular functions. Biochem J. 423:253–264. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rienksma RA, Suarez-Diez M, Mollenkopf HJ,
Dolganov GM, Dorhoi A, Schoolnik GK, Dos Santos Martins VA,
Kaufmann SH, Schaap PJ and Gengenbacher M: Comprehensive insights
into transcriptional adaptation of intracellular mycobacteria by
microbe-enriched dual RNA sequencing. BMC Genomics. 16:342015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mendes-Giannini MJ, Hanna SA, da Silva JL,
Andreotti PF, Vincenzi LR, Benard G, Lenzi HL and Soares CP:
Invasion of epithelial mammalian cells by Paracoccidioides
brasiliensis leads to cytoskeletal rearrangement and apoptosis of
the host cell. Microbes Infect. 6:882–891. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Y, Khoo HE and Esuvaranathan K:
Effects of bacillus Calmette-Guerin and interferon-alpha-2B on
human bladder cancer in vitro. Int J Cancer. 71:851–857. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dourado DF, Fernandes PA and Ramos MJ:
Mammalian cytosolic glutathione transferases. Curr Protein Pept
Sci. 9:325–337. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Simic T, Savic-Radojevic A,
Pljesa-Ercegovac M, Matic M and Mimic-Oka J: Glutathione
S-transferases in kidney and urinary bladder tumors. Nat Rev Urol.
6:281–289. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Johansson K, Järvliden J, Gogvadze V and
Morgenstern R: Multiple roles of microsomal glutathione transferase
1 in cellular protection: A mechanistic study. Free Radic Biol Med.
49:1638–1645. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
West AP, Brodsky IE, Rahner C, Woo DK,
Erdjument-Bromage H, Tempst P, Walsh MC, Choi Y, Shadel GS and
Ghosh S: TLR signalling augments macrophage bactericidal activity
through mitochondrial ROS. Nature. 472:476–480. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ke HL, Lin J, Ye Y, Wu WJ, Lin HH, Wei H,
Huang M, Chang DW, Dinney CP and Wu X: Genetic variations in
glutathione pathway genes predict cancer recurrence in patients
treated with transurethral resection and bacillus Calmette-Guerin
instillation for non-muscle invasive bladder cancer. Ann Surg
Oncol. 22:4104–4110. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Visvikis O, Boyer L, Torrino S, Doye A,
Lemonnier M, Lorès P, Rolando M, Flatau G, Mettouchi A, Bouvard D,
et al: Escherichia coli producing CNF1 toxin hijacks Tollip to
trigger Rac1-dependent cell invasion. Traffic. 12:579–590. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu L, Wang L, Luo X, Zhang Y, Ding Q,
Jiang X, Wang X, Pan Y and Chen Y: Tollip, an intracellular
trafficking protein, is a novel modulator of the transforming
growth factor-β signaling pathway. J Biol Chem. 287:39653–39663.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shah JA, Vary JC, Chau TT, Bang ND, Yen
NT, Farrar JJ, Dunstan SJ and Hawn TR: Human TOLLIP regulates TLR2
and TLR4 signaling and its polymorphisms are associated with
susceptibility to tuberculosis. J Immunol. 189:1737–1746. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Montaner LJ, da Silva RP, Sun J,
Sutterwala S, Hollinshead M, Vaux D and Gordon S: Type 1 and type 2
cytokine regulation of macrophage endocytosis: Differential
activation by IL-4/IL-13 as opposed to IFN-gamma or IL-10. J
Immunol. 162:4606–4613. 1999.PubMed/NCBI
|
|
30
|
Jung JY and Robinson CM: IL-12 and IL-27
regulate the phagolysosomal pathway in mycobacteria-infected human
macrophages. Cell Commun Signal. 12:162014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rivero-Lezcano OM, González-Cortés C,
Reyes-Ruvalcaba D and Diez-Tascón C: CCL20 is overexpressed in
Mycobacterium tuberculosis-infected monocytes and inhibits the
production of reactive oxygen species (ROS). Clin Exp Immunol.
162:289–297. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kadhim SA, Chin JL, Batislam E, Karlik SJ,
Garcia B and Skamene E: Genetically regulated response to
intravesical bacillus Calmette Guerin immunotherapy of orthotopic
murine bladder tumor. J Urol. 158:646–652. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Poirier V, Bach H and Av-Gay Y:
Mycobacterium tuberculosis promotes anti-apoptotic activity of the
macrophage by PtpA protein-dependent dephosphorylation of host
GSK3α. J Biol Chem. 289:29376–29385. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Castandet J, Prost JF, Peyron P,
Astarie-Dequeker C, Anes E, Cozzone AJ, Griffiths G and
Maridonneau-Parini I: Tyrosine phosphatase MptpA of Mycobacterium
tuberculosis inhibits phagocytosis and increases actin
polymerization in macrophages. Res Microbiol. 156:1005–1013. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Islam N, Kanost AR, Teixeira L, Johnson J,
Hejal R, Aung H, Wilkinson RJ, Hirsch CS and Toossi Z: Role of
cellular activation and tumor necrosis factor-alpha in the early
expression of Mycobacterium tuberculosis 85B mRNA in human alveolar
macrophages. J Infect Dis. 190:341–351. 2004. View Article : Google Scholar : PubMed/NCBI
|
